A Study to Assess the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Renal Function and Subjects With Varying Degrees of Renal Impairment
Completed · Phase 1
Conditions studied: Renal Impairment
In brief
The purpose of this study is to assess the effect of varying degrees of renal impairment (mild, moderate, severe and end stage renal disease) compared with subjects with normal renal function on the pharmacokinetics of the hydrocodone bitartrate extended-release tablet.
Key facts
- Study ID
- NCT01319266
- Run by
- Cephalon
- People needed
- 55
- Starts
- 2011-03-01
- Expected to finish
- 2011-10-01
- Last updated by the study team
- 2012-04-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Clinical Pharmacology of Miami — Miami, Florida, United States
- Orlando Clinical Research — Orlando, Florida, United States
- DaVita — Minneapolis, Minnesota, United States
- New Orleans Center — Knoxville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.